Market Research Report
Global Emerging Sleep Apnea Devices and Platforms Market: Analysis and Forecast, 2021-2030
|Published by||BIS Research Inc.||Product code||959511|
|Published||Content info||356 Pages
Delivery time: 1-2 business days
|Global Emerging Sleep Apnea Devices and Platforms Market: Analysis and Forecast, 2021-2030|
|Published: September 3, 2020||Content info: 356 Pages||
"Global Emerging Sleep Apnea Devices and Platforms Market to Reach $13.18 Billion by 2030."
ActiGraph, LLC., BMC Medical Co., Ltd, Braebon Medical Corporation, Cadwell Industries, Inc., Circadiance, Cleveland Medical Devices Inc., Compumedics Limited, Fisher & Paykel Healthcare Limited, General Electric Company, Glidewell, Inspire Medical Systems, Inc., Itamar Medical Ltd., Koninklijke Philips N.V., LivaNova PLC, Lowenstein Medical GmbH & CO. KG, Medical Depot, Inc., Medtronic plc, Natus Medical Incorporated, Nonin, ResMed, Smiths Group plc, SOmnoMed.com, Somnetics International, Inc., VYAIRE MEDICAL, INC.
Company Snapshots: Beddit (Apple, Inc.), Dental Arts Laboratories, Inc., Dreem, Oura, PMD Device Solutions Limited, ProSomnus Sleep Technologies, Provent Sleep Therapy, LLC, Respicardia, Inc., and Signifier Medical Technologies Limited
The global emerging sleep apnea devices and platforms market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $4,882.2 million in FY2019, and it is expected to grow at a CAGR of 9.94% during the forecast period, 2021-2030. Presently, more than 45 companies are operating in this market, including already existing healthcare companies and emerging healthcare companies.
Moreover, during COVID-19 pandemic, various regulatory agencies such as Food and Drug Administration (FDA), U.S. and Therapeutic Goods Administration (TGA) have approved the usage of positive airway pressure (PAP) devices such as continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) devices, and adaptive servo ventilators (ASVs) as ventilators. Additionally, the demand for oral appliances has also increased significantly due to the high risk of infection in the case of COVID-19 positive sleep apnea patients. In the situation, the usage of a PAP device can increase the risk of infection for the patient's peers. Other devices with increased demand included home sleep testing devices and sleep apnea screening and monitoring devices and solutions. In addition to conventional devices, emerging therapeutic and diagnostic and monitoring devices have also witnessed a significant increase in demand.
Our healthcare experts are continuously analyzing the impact of regulatory and industrial decisions on the global emerging sleep apnea devices and platforms market. The market is driven by certain factors, including growing awareness regarding the ill effects of untreated sleep apnea, increasing usage of oral appliances for sleep apnea treatment, rising demand for portable sleep apnea devices, and technological advancements in sleep apnea treatment and diagnosis devices and platforms.
The market is favored by the development of emerging therapeutics and diagnostic, monitoring devices and solutions, and increasing adoption of the sleep apnea devices.
Within the research report, the market is segmented based on product type, end user, and regional analysis. Each of these segments covers the market's snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.